The electrophoretic pattern of the large microtubule-associated protein, MAP2, changes during rat brain development. Immunoblots of NaDodSO4 extracts obtained from the cerebral cortex, cerebellum, and thalamus at 10-15 days after birth reveal only a single electrophoretic species when probed with any of three MAP2 monoclonal antibodies. By contrast, adult MAP2 contains two immunoreactive species, MAP2a and MAP2b. The single band of MAP2 from immature brain electrophoretically comigrates with adult MAP2b. Between postnatal days 17 and 18, immature MAP2 simultaneously resolves into two species in both the cerebellum and cerebral cortex. Immunoblots of NaDodSO4 extracts from spinal cord demonstrate the adult complement of MAP2 by day 10, indicating that MAP2 does not change coordinately throughout the entire central nervous system. In vitro cAMPdependent phosphorylation of immature MAP2 causes a band split reminiscent of that seen during brain development in vivo. The possibility that the developmentally regulated changes observed in MAP2 during brain maturation are due to timed phosphorylation events is discussed.Microtubule-associated protein 2 (MAP2) is a heat-stable phosphoprotein (Mr 300,000) that copurifies with brain microtubules in vitro and maintains a constant stoichiometry to tubulin through several cycles of temperature-dependent assembly and disassembly (1, 2). It is one of a number of high molecular weight polypeptides associated with in vitro assembled brain microtubules, collectively referred to as HMW MAPs (3). NaDodSO4/urea/polyacrylamide gel electrophoresis separates MAP2 into two closely migrating polypeptides, which we designate MAP2a and MAP2b for the slower and faster migrating species, respectively. In vitro, MAP2 will stimulate the assembly of purified tubulin, lowering the critical concentration for tubulin assembly (1). When such preparations are visualized with the electron microscope, MAP2 appears as regularly spaced filamentous sidearms decorating the surface of microtubules (1), reminiscent of the appearance of microtubules in situ (4,5). In addition to its interaction with microtubules, MAP2 interacts with neurofilaments and actin filaments (3,(6)(7)(8)(9)(10). This suggests that MAP2 may act as a crosslinker mediating the interaction between microtubules, other cytoskeletal elements, and cytoplasmic organelles. Evidence is accumulating which suggests that the relative affinity of MAP2 for different cytoskeletal structures may be controlled by its degree of phosphorylation (10-12).Radioimmunoassay of a variety of tissues suggests that only brain contains significant amounts of MAP2 (13). Fluorescence, light, and immunoelectron microscopic studies using monoclonal antibodies have localized MAP2 in neurons but not glia (13,14). Biochemical and morphological studies further indicate that within nerve cells more of this protein is present in dendrites and cell bodies than in axons (14-16). Furthermore, MAP2 from neonatal rat brain was shown to be biochemically distinct from its a...